Department of Internal Medicine, Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Department of Gastroenterology, Hepatology and Nutrition, Digestive Disease and Surgical Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Gastrointest Endosc. 2021 Jun;93(6):1401-1407.e1. doi: 10.1016/j.gie.2020.11.028. Epub 2020 Dec 13.
Some data suggest that individuals with numerous, <10-mm, rectosigmoid hyperplastic polyps (HPs) are at average risk for the development of metachronous advanced adenomatous neoplasia. Guidelines suggest that these individuals do not need surveillance colonoscopy and should be followed akin to individuals with a normal colonoscopy. Less is known of the risk of metachronous neoplasia because of ≥1 HPs <10 mm proximal to the sigmoid colon. We compared the risk of metachronous neoplasia between individuals with small HPs and those with normal colonoscopy, specifically addressing the impact of location and number of HPs on risk.
Colonoscopy and pathology reports from patients with ≥2 colonoscopies between 2004 and 2014 were reviewed. Exclusions included inpatients; age <40 or >75 years; and family or personal history of colorectal cancer, inflammatory bowel disease, previous colorectal surgery, or a previous colonoscopy with any adenoma, sessile serrated lesion (SSL), or HP ≥10 mm. The risk of metachronous neoplasia, including adenomas and SSLs, was compared in individuals with a normal index colonoscopy and those with <10-mm HPs stratified by location and number of HPs.
After exclusion, 1795 patients were included. At index colonoscopy, 82% (n = 1469) had a normal examination, 12% (219) had only 1, and 6% (107) had between 2 and 9 HPs <10 mm. Compared with patients with a normal index colonoscopy, patients with a proximal (odds ratio, 3.82; 95% confidence interval, 1.77-7.53) or distal HP (odds ratio, 2.23; 95% confidence interval, 1.18-4.00) had an increased risk of metachronous SSLs but not adenomas.
Patients with small proximal and distal HPs are at increased risk of metachronous SSLs. These preliminary findings warrant consideration during surveillance recommendations and future studies in larger cohorts.
一些数据表明,存在大量<10mm 的直肠乙状结肠增生性息肉(HP)的个体,发生结肠腺瘤性异型增生的风险为中等。指南建议这些个体无需进行结肠镜监测,可将其视为结肠镜检查正常的个体进行随访。然而,由于乙状结肠近端存在≥1 个<10mm 的 HP,对这些个体发生结肠腺瘤性异型增生的风险了解较少。本研究比较了存在小 HP 和结肠镜检查正常个体的结肠腺瘤性异型增生发生风险,特别是探讨了 HP 的位置和数量对风险的影响。
回顾 2004 年至 2014 年间进行了≥2 次结肠镜检查的患者的结肠镜检查和病理报告。排除标准包括住院患者;年龄<40 岁或>75 岁;有结直肠癌、炎症性肠病、既往结直肠手术或既往结肠镜检查发现任何腺瘤、无蒂锯齿状病变(SSL)或≥10mm HP 的家族或个人病史。比较了结肠镜检查正常的个体和存在<10mm HP 的个体(按 HP 的位置和数量分层)的结肠腺瘤性异型增生(包括腺瘤和 SSL)发生风险。
排除后共纳入 1795 例患者。在索引结肠镜检查中,82%(n=1469)检查正常,12%(219)仅有 1 个,6%(107)存在 2-9 个<10mm 的 HP。与结肠镜检查正常的患者相比,存在近端(优势比,3.82;95%置信区间,1.77-7.53)或远端 HP(优势比,2.23;95%置信区间,1.18-4.00)的患者发生 SSL 的风险增加,但发生腺瘤的风险未增加。
存在小的近端和远端 HP 的患者发生 SSL 的风险增加。这些初步发现值得在监测建议和未来的大型队列研究中进一步考虑。